From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Kooth – with the ominous combination of being an AIM Awards 2024 “winner” and that being “Diversity Champion”, now contract disappointment (natch!)…

By Steve Moore | Friday 18 October 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Just over a week ago at the 2024 AIM Awards self-indulgent beanfeast (Oops I mean, ‘bringing of the unique AIM global community together to celebrate the remarkable achievements of resilient and innovative companies listed on AIM’, natch!), it was the “Diversity Champion Award” for Kooth plc (KOO). I’ve noted that already an award nomination has proven a counter-indicator – and that has been particularly so with the “Diversity Champion” category history. Already shares in Kooth closed the day of the self-indulgent beanfeast (Oops, I’ve done it again!), at 288p having closed at 345p as recently as in September and 318p as recently as 7th October. With all that, what about a now intra-day (also ominous!) “Update on Pennsylvania pilot contract” announcement?

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 07:07:26